| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Amyotrophic lateral sclerosis | 2 | 4 | |
| Mast cell activation syndrome | 1 | 0 | |
| Myalgic encephalomyelitis/chronic fatigue syndrome | 1 | 3 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 7 |